A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

They work by mimicking the action of a hormone called glucagon-like peptide 1 (hence GLP-1), stimulating the body to produce more insulin and decreasing blood sugar spikes by slowing digestion.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

The toxic bite of a Gila monster can kill a human, but a specific ingredient in the cocktail of the lizard's venom is the ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...